Dr James Geake
School of Medicine
College of Health
Dr James B. Geake Head of Respiratory Medicine, Lyell McEwin Hospital. TITLEHOLDER. Respiratory and Sleep Specialist.No other information available
| Year | Citation |
|---|---|
| 2025 | Inauen, J., Geake, J., Sawka, A., Labroome, S., Hoffmann, R., & Barry, S. (2025). A Clinical Case Series of BCGosis as a Rare Complication of Intravesical BCG. Clinical Genitourinary Cancer, 23(1), 4 pages. Scopus1 WoS1 Europe PMC1 |
| 2025 | Inauen, J., LaBroome, S., Maldari, A., Stevens, N. E., Geake, J. B., Lynn, D. J., & Barry, S. (2025). Efficacy of Bacille Calmette–Guérin Against COVID-19 Hospitalisation: A Meta-Analysis and Systematic Review of Randomised Control Trials. Vaccines, 13(3), 267-1-267-15. |
| 2025 | Barry, S. E., Sawka, A., Maldari, A., Inauen, J., LaBroome, S., & Geake, J. B. (2025). Macrophage Dysfunction in Tuberculosis–Diabetes Mellitus Comorbidity: A Scoping Review of Immune Dysregulation and Disease Progression. Diabetology, 6(5), 21 pages. |
| 2025 | Selway, C. A., Shephard, L., Hobby, M., Vandelannoote, K., Lease, C., Cunliffe, D., . . . Leong, L. E. X. (2025). Genomic characterization and SNP analysis connect respiratory infections caused by Mycobacterium intracellulare with a pool facility. Microbial Genomics, 11(12), 8 pages. |
| 2024 | Subramaniam, S., Kanhere, M., Shephard, L., Burke, A., Saxon, S., & Geake, J. (2024). A case of severe Mycobacterium thermoresistibile pneumonia. Respirology Case Reports, 12(3), 6 pages. Scopus3 WoS2 Europe PMC3 |
| 2024 | Schultz, A., Balaguruswamy, S., Dentice, R., Dobler, C. C., Geake, J., Gibson, P., . . . Seale, H. (2024). Thoracic Society of Australia and New Zealand position statement: The safe clinical use of sputum induction for bio-sampling of the lower airways in children and adults. Respirology, 29(5), 372-378. Scopus1 Europe PMC1 |
| 2023 | Sawka, A., Geake, J., Stapledon, R., & Barry, S. (2023). Tuberculosis, focussed tools and the right schools: estimated impact and cost of a targeted student screening programme for tuberculosis infection. Internal Medicine Journal, 53(6), 978-984. |
| 2021 | Xu, A., Lawton, E., Smith, S., Kalro, A., & Geake, J. (2021). Pulmonary AL amyloidosis and multiple myeloma presenting as cough with diffuse pulmonary opacities. Respirology Case Reports, 9(7). |
| 2020 | Geake, J., Ballard, E., O'Rourke, P., Wainwright, C. E., Reid, D. W., & Bell, S. C. (2020). Centralised versus outreach models of cystic fibrosis care should be tailored to the needs of the individual patient. Internal Medicine Journal, 50(2), 232-235. |
| 2018 | Geake, J., & Bell, S. C. (2018). Bronchiectasis: Yet another systemic disease?. Respirology, 23(9), 797-798. |
| 2017 | Ramsay, K. A., Sandhu, H., Geake, J. B., Ballard, E., O'Rourke, P., Wainwright, C. E., . . . Bell, S. C. (2017). The changing prevalence of pulmonary infection in adults with cystic fibrosis: a longitudinal analysis. Journal of Cystic Fibrosis, 16(1), 70-77. Scopus31 WoS30 Europe PMC26 |
| 2017 | Viberg, L. T., Sarovich, D. S., Kidd, T. J., Geake, J. B., Bell, S. C., Currie, B. J., & Price, E. P. (2017). Within-host evolution of burkholderiapseudomallei during chronic infection of seven Australasian cystic fibrosis patients. mBio, 8(2), e00356-17-1-e00356-17-16. Scopus57 WoS52 Europe PMC56 |
| 2016 | Tan, C. K., Say, G. Q., & Geake, J. B. (2016). Long-term safety of tiotropium delivered by respimat® SoftMist™ inhaler: Patient selection and special considerations. Therapeutics and Clinical Risk Management, 12, 1433-1444. Scopus4 WoS4 Europe PMC4 |
| 2015 | Geake, J., Dabscheck, E., Wood-Baker, R., & Cates, C. (2015). dacaterol, a once-daily beta2-agonist, versus twice-daily beta2-agonists or placebo for chronic obstructive pulmonary disease. Cochrane Database of Systematic Reviews, 2015(1), 85 pages. Scopus48 WoS22 Europe PMC24 |
| 2015 | Geake, J., Hammerschlag, G., Nguyen, P., Wallbridge, P., Jenkin, G. A., Korman, T. M., . . . Steinfort, D. P. (2015). Utility of EBUS-TBNA for diagnosis of mediastinal tuberculous lymphadenitis: A multicentre Australian experience. Journal of Thoracic Disease, 7(3), 439-448. Scopus59 |
| 2015 | Jong, T., Geake, J., Yerkovich, S., & Bell, S. C. (2015). Idiosyncratic reactions are the most common cause of abnormal liver function tests in patients with cystic fibrosis. Internal Medicine Journal, 45(4), 395-401. Scopus9 Europe PMC3 |
| 2015 | Geake, J., Reid, D., Currie, B., Bell, S., Bright-Thomas, R., Dewar, J., . . . Flight, W. (2015). An international, multicentre evaluation and description of Burkholderia pseudomallei infection in cystic fibrosis. BMC Pulmonary Medicine, 15(1), 116-1-116-10. Scopus23 WoS19 Europe PMC17 |
| 2014 | Geake, J., Tay, G., Callaway, L., & Bell, S. C. (2014). Pregnancy and cystic fibrosis: Approach to contemporary management. Obstetric Medicine, 7(4), 147-155. Scopus31 |
| 2014 | Geake, J. B., Ritchey, D. M., Burke, J., Halliday, A., Wood-Baker, R., & Maguire, G. (2014). Sudden death in a young male with a recent pneumothorax: a case report. European Respiratory Review, 23(131), 145-147. Scopus4 WoS2 Europe PMC1 |
| 2012 | Geake, J. B., & Maguire, G. (2012). Acute spontaneously resolving pulmonary vasculitis: a case report. Case Reports in Immunology, 2012, 706838-1-706838-3. |
| 2012 | Geake, J., Dabscheck, E., & Reid, D. (2012). Hemolysis, elevated liver enzymes, and low platelet (HELLP) syndrome in a 26-year-old woman with cystic fibrosis: A case report. Journal of Medical Case Reports, 6(1). Scopus1 |
| Date | Role | Research Topic | Location | Program | Supervision Type | Student Load | Student Name |
|---|---|---|---|---|---|---|---|
| 2019 - ongoing | Principal Supervisor | Role of a nurse navigator in lung cancer diagnosis | Lyell McEwin Hospital | - | Other | Part Time | Phoebe Waters |
| Date | Role | Committee | Institution | Country |
|---|---|---|---|---|
| 2018 - ongoing | Treasurer | SA/NT Branch Committee | Thoracic Society of Australia and New Zealand | Australia |
Connect With Me
External Profiles
